Home / Resource Library / Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

Results of a phase III study examining rituximab combined with high does chemotherapy for treatment of B-cell lymphomas in children.